About Atb Therapeutics
Atb Therapeutics is a public limited company (NV/SA) based in Marche-en-Famenne, founded in 2017. Its main activity is classified as "Vervaardiging van farmaceutische grondstoffen". For the 2025 financial year, Atb Therapeutics reported a loss of €8 million. That makes 8 loss-making financial years in a row for Atb Therapeutics. Revenue was not published, which is common for abbreviated accounts. The gross margin came to -€513,236. It employed an average of 22 full-time equivalents. Equity stands at €5.1 million, a solvency ratio of 48%. In 2018 it was -€145,718. 8 annual accounts are available, covering 2018 to 2025.
- Sectors
- Farms
- Signals
-
Reporting lossesReporting losses € -8.00M
The company reported a loss in the latest financial year.
Negative cashflowNegative cashflow € -2.20MOperating cash flow was negative in the latest financial year.
Negative EBITDANegative EBITDA € -2.41MEBITDA is negative: operating activities are loss-making.
High social debt vs. personnel costsHigh social debt vs. personnel costs 27.1%Social debts are a high share of personnel costs, which may indicate social security arrears.
Strong equityStrong equity € 5.08MStrong equity provides a buffer against setbacks.
Low riskLow risk 47.8%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 1.81A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
- Directors
- Capital Et Croissance, Magman, Chiton Rocks, +3 more
- Shareholders
- Orsa Tech 24,14%, Vives Inter-University Fund 4,97%, Orsa Fund 2,09%, +1 more
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
-513K
|
€
-885K
|
€
-51K
|
€
407K
|
|
|
€
-2.41M
|
€
-1.67M
|
€
-785K
|
€
-481K
|
|
|
€
-8.00M
|
€
-3.29M
|
€
-2.13M
|
€
-1.35M
|
|
|
€
5.08M
|
€
13.08M
|
€
-3.16M
|
€
-1.03M
|
|
|
47.76%
|
93.19%
|
-147.43%
|
-47.40%
|
|
|
€
5.56M
|
€
955K
|
€
5.31M
|
€
3.22M
|
|
|
€
9.31M
|
€
13.50M
|
€
979K
|
€
908K
|
|
|
22
|
9
|
10
|
12.40
|
Publications 14
All publications- Statuten (Vertaling, Co?Rdinatie, Overige Wijzigingen, ?) - Kapitaal - Aandelen 26/08/2026
- Statuts (Traduction, Coordination, Autres Modifications, ?) - Capital, Actions 26/08/2026
- Statuten (Vertaling, Co?Rdinatie, Overige Wijzigingen, ?) - Kapitaal - Aandelen 13/04/2026
- Statuts (Traduction, Coordination, Autres Modifications, ?) - Capital, Actions 13/04/2026
- Statuts (Traduction, Coordination, Autres Modifications, ?) - Capital, Actions 07/07/2025
Frequently asked questions
Answers to the most common questions about Atb Therapeutics, based on official government data and the filed annual accounts.
What is the VAT number of Atb Therapeutics?
The VAT number of Atb Therapeutics is BE0677.980.015.
How many employees work at Atb Therapeutics?
In 2025, Atb Therapeutics employed 22.00 full-time equivalents (FTE).
When was Atb Therapeutics established?
Atb Therapeutics was founded in 06-07-2017.
What is the official address of Atb Therapeutics?
The official address of Atb Therapeutics is Aye, Rue De La Science 8 Marche-En-Famenne 6900.
What is the legal form of Atb Therapeutics?
The juridical form of Atb Therapeutics is Public limited company (NV/SA).
What is the annual revenue of Atb Therapeutics?
The 2025 accounts of Atb Therapeutics do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
Is Atb Therapeutics a reliable company?
Atb Therapeutics is a registered Rechtspersoon with company number 0677.980.015 and can be verified through the official CBE database.
What is the credit limit of Atb Therapeutics?
The estimated credit limit of Atb Therapeutics is €247,278.
Is Atb Therapeutics still active?
Atb Therapeutics currently has the status "Normal situation" and is active.